Raymond James Financial
TECH icon

Raymond James Financial’s Bio-Techne TECH Stock Holding History

Raymond James Financial’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.9M Sell
649,551
-97,250
-13% -$5.84M 0.01% 1116
2025
Q4 		$44M Buy
746,801
+76,570
+11% +$4.65M 0.01% 892
2025
Q3 		$37.3M Sell
670,231
-21,859
-3% -$1.17M 0.01% 989
2025
Q2 		$35.6M Buy
692,090
+68,786
+11% +$3.46M 0.01% 969
2025
Q1 		$36.5M Buy
623,304
+5,796
+0.9% +$393K 0.01% 899
2024
Q4 		$44.5M Buy
+617,508
New +$45.3M 0.02% 783

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial's TECH Position: Q1 2026 in Review

Raymond James Financial reduced its Bio-Techne (TECH) stake by 13% in Q1 2026, selling an estimated $5.84M and leaving 649,551 shares worth $33.9M. The position accounts for 0.01% of the portfolio, ranked #1116.

Raymond James Financial first reported a position in TECH in Q4 2024 and has held it in 6 quarters since. The position peaked at $44.5M in Q4 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Raymond James Financial held 649,551 shares of Bio-Techne worth $33.9M as of Q1 2026.
  • Raymond James Financial sold 97,250 Bio-Techne shares in Q1 2026, an estimated $5.84M.
  • Bio-Techne made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1116 holding.
  • Raymond James Financial first reported a position in Bio-Techne in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Bio-Techne position peaked at $44.5M in Q4 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.